| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00360971 Details | 2017-12-26 Interventional | 3 | 21 | Cisplatin Head and Neck N… Mucositis Stomatitis Head and Neck C… Pain Radiation Toxic… | Due to positive preliminary results from other palifermin studies. This study terminated early with 21 subjects accrued out of 298 planned, therefore no statistical testing was performed. The termination was decided due to positive preliminary results from other palifermin studies. | |||
| NCT03059303 Details | 2017-12-22 Interventional | 1 | 72 | Dexlansoprazole Lansoprazole Odalasvir Omeprazole Simeprevir Healthy | Decision to discontinue development of investigational Hep C treatment regimen JNJ-4178: 3
direct acting antivirals - AL-335, ODV & SMV. - | |||
| NCT02412917 Details | 2017-12-22 Interventional | 3 | 237 | Valacyclovir Herpes Zoster Neuralgia Neuralgia, Post… Postherpetic Ne… Shingles | - - | |||
| NCT01377441 Details | 2017-12-22 Interventional | 4 | 6 | Anti-Inflammato… Anti-Inflammato… Ibuprofen Inflammatory Re… | Samples lost during Hurricane Sandy. Study now taking place at other medical centers. - | |||
| NCT00407641 Details | 2017-12-22 Interventional | 4 | 0 | Dalteparin Heparin Heparin, Low-Mo… Tinzaparin Diabetes Mellit… Hemodialysis | Financial and administrative matters did not allow collaboration among centers. - | |||
| NCT00384657 Details | 2017-12-22 Interventional | 3 | 0 | Ferric Oxide, S… Iron Anemia Heart Failure Kidney Diseases Renal Insuffici… Chronic Heart F… Chronic Kidney … | Lack of cooperation among centers, Financial reasons - | |||
| NCT02263365 Details | 2017-12-20 Interventional | 3 | 40 | Antidiarrheals Loperamide Dehydration Dehydration, Di… | Unable to meet study requirements Study only accrued 40 patients. Due to issues with enrollment and study procedures compliance it was decided to terminate the study. Data analysis will not be done for this study. This study has been closed with the internal review board. | |||
| NCT03307941 2016-000935-42 Details | 2017-12-19 Interventional | 1/2 | 0 | Fluorouracil Oxaliplatin Adenocarcinoma Esophageal Neop… Esophageal Squa… Adenocarcinoma … Adenocarcinoma … Squamous Cell C… | Suspended collaboration with the company providing the study drug - | |||
| NCT01394523 Details | 2017-12-19 Interventional | 2/3 | 39 | Bupivacaine Hernia, Umbilic… Umbilical Herni… | Interim power analysis was prohibitive to continuing the study - | |||
| NCT01051791 Details | 2017-12-19 Interventional | 2 | 13 | Everolimus Carcinoma Carcinoma, Squa… Squamous Cell C… Squamous Cell C… | - - | |||
| NCT02831205 Details | 2017-12-15 Interventional | 4 | - | Chromium Cobalt Everolimus Coronary Artery… Coronary Diseas… Myocardial Isch… Percutaneous Tr… | Due to current BVS safety issue - | |||
| NCT02047500 Details | 2017-12-15 Interventional | 1 | 19 | Gemcitabine Paclitaxel Pancreatic Neop… Pancreatic Canc… | The trial has been terminated earlier following the company decision to discontinue the
clinical development of Evofosfamide - | |||
| NCT01469221 2011-003517-42 Details | 2017-12-15 Interventional | 3 | 47 | Apaziquone Non-Muscle Inva… Urinary Bladder… Bladder Cancer | Business reason - | |||
| NCT00585546 NCT00701116 Details | 2017-12-15 Interventional | 1 | 18 | Clenbuterol Cardiomyopathie… Cardiomyopathy,… Heart Failure Dilated Cardiom… | No longer could obtain clenbuterol Because a new standard of care was developed during the start of the trial, the trial was stopped for futility in enrollment. The public should exercise great caution in drawing conclusions from such a small sample size. | |||
| NCT03100877 Details | 2017-12-13 Interventional | 1/2 | 0 | Cyclophosphamid… Lenalidomide Lenograstim Mechlorethamine Melphalan Mitogens Nitrogen Mustar… Leukemia, Plasm… Multiple Myelom… Neoplasms, Plas… Plasma Cell Leu… Plasma Cell Mye… | Feasibility Issues - | |||
| NCT01390506 2011-001074-26 Details | 2017-12-13 Interventional | 2 | 0 | Selenious Acid Sodium Selenite Heart Arrest Cardiac Arrest | The company did not provide the study product - | |||
| NCT02857244 Details | 2017-12-12 Interventional | 2 | 0 | Donepezil Duloxetine Hydr… Modafinil Parkinson Disea… Parkinson's Dis… | Site did not obtain LIRB approval due to medication usage. - | |||
| NCT02227329 Details | 2017-12-12 Interventional | 1/2 | [1 Refs] | 39 | Calcium heparin Ethanol Heparin Communicable Di… Infections Sepsis Bloodstream Inf… Bloodstream Inf… Catheter-relate… | Publication of guidelines advising against the use of ethanol locks. Due to European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines on chronic intestinal failure in adults advising against ELT, we conducted an interim analysis. The study was terminated early; further study would not change outcome. | ||
| NCT02158936 Details | 2017-12-12 Interventional | 3 | 356 | Azacitidine Myelodysplastic… Preleukemia Syndrome Thrombocytopeni… Thrombocytopaen… | - The IDMC recommended terminating the study for futility (primary) and safety (secondary). Due to early termination of the trial, the final analysis of OS took place at the same time as the final analysis of the primary end point. | |||
| NCT00794547 NCT00470431 Details | 2017-12-12 Interventional | 1/2 | [1 Refs] | 34 | Calcitriol Carcinoma, Non-… Lung Neoplasms Non Small Cell … | - - |